Organizational Performance Management Table Essay Example for Free

Organizational Performance Management Table EssayAfter you have completed your individual investigate on your chosen lineament of health care organization, collaborate with your Learning Team to complete this table. Then, refer to this table as you collaborate to write your paper. Include this table as an cecal appendage to your paper.Fill in the necessary information in each cell, but be as succinct as possible.1. Provide names of or link to specific organizations. Summarize key products or services provided by each type of organization and identify the primary customers they serve. Organization OneOrganization 2Organization Threehttp//www.fda.gov/U.S. victuals and Drug Administration2. Outline the overall content of the study regulations, accreditation requirements, and other standards that affect each organization. Provide the title, section, parts, or subparts or the numbering system and so on of the specific regulations or accreditation requirements.For example Use of electronic signatures in electronic medical records is equivalent to handwritten signatures on paper FDA regulation Title 21 CFR Part 11, Subpart C, 11.200 Electronic Signature http//www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?cfrpart=11Organization OneOrganization iiOrganization ThreeFood and Drug Administration Safety and Innovation Act (FDASIA) Because of their importance, an agencys rulemaking plans are of great interest to a wide range to stakeholders. Therefore, the Federal brass publishes a semi-annual agenda of upcoming regulations in the Federal Register, usually in the Spring and Fall. As part of FDAs Transparency Initiative and FDA Transparency Results answerableness Credibility Knowledge Sharing (TRACK), we are also providing periodic updates on FDAs Unified Agenda rulemakings. On the Unified Agenda-TRACK Web page, we will observe an updated agenda of FDAs Unified Agenda rulemakings.3. Highlight the effect of each organizations regulations, accred itation requirements, and other standards on the risk- and quality-management functions and activities.Organization OneOrganization TwoOrganization ThreeThe scope of FDAs regulatory authority is very broad. FDAs responsibilities are closely related to those of several other government agencies. Often forestall and confusing for consumers is determining the appropriate regulatory agency to contact. The following is a list of traditionally-recognized product categories that fall under FDAs regulatory jurisdiction however, this is not an exhaustive list.In general, FDA regulatesFoods, includingdietary supplementsbottled waterfood additivesinfant formulasother food products (although the U.S. Department of Agriculture plays a lead role in regulation aspects of some meat, poultry, and egg products) Drugs,includingprescription drugs (both brand-name and generic)non-prescription (over-the-counter) drugsBiologics, includingvaccinesblood and blood productscellular and gene therapy products tissue and tissue productsallergenicsMedical Devices, includingsimple items like tongue depressors and bedpanscomplex technologies much(prenominal) as heart pacemakersdental devicessurgical implants and prostheticsElectronic Products that give off radiation, includingmicrowave ovensx-ray equipmentlaser productsultrasonic therapy equipmentmercury vapor lampssunlampsCosmetics, includingcolor additives set in motion in makeup and other personal care products skin moisturizers and cleansersnail polish and perfumeVeterinary Products, includinglivestock feedspet foodsveterinary drugs and devicesTobacco Products, including canscigarette tobaccoroll-your-own tobaccosmokeless tobacco4. Specify components of performance-management systemspolicies and procedures, self-audits, benchmarking, complaint management, corrective or preventive action, education and training, communication, and other mechanismsto be used by each organization.Organization OneOrganization TwoOrganization ThreeRisk comm unication staff Our Risk colloquy Staffs objective is to assess and enhance FDAs approaches to in effect communicate the risks and benefits of using FDA-regulated products. This includes providing leadership in identifying, developing, conducting and promoting cross-cutting research, promoting understandable communication, and finding ways to improve the consistency and effectiveness of our communication approaches. This program also directs the activities of FDAs Risk Communication Advisory Committee, which was established to advise on strategies and programs to communicate the risks and benefits of FDA-regulated products so as to facilitate optimal use to review and evaluate FDAs and others research relevant to such communication and to facilitate interactively sharing risk and benefit information with the public to help people make informed independent judgments about use of FDA-regulated products.Our major functions includeCoordinating development of agency policies on risk co mmunication practices.Coordinating agency strategic planning activities concerning risk communications.Coordinating agency research agenda for risk communication methods.Facilitating development and sharing of risk communication best practices and standard operating procedures.Conducting risk communications research on methodological and cross-cutting issues.Leading management and coordination of the FDA Risk Communication Advisory Committee.Staffing and co-leading FDAs Communications Council5. Provide links to any relevant sources that will be useful as your Learning Team completes the paper.Organization OneOrganization TwoOrganization ThreeFda.gov